455 related articles for article (PubMed ID: 32727475)
21. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.
Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM
J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133
[TBL] [Abstract][Full Text] [Related]
22. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from?
Toogood PL; Clauw DJ; Phadke S; Hoffman D
Pharmacol Res; 2021 Mar; 165():105465. PubMed ID: 33529750
[TBL] [Abstract][Full Text] [Related]
23. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.
Sweetman E; Kleffmann T; Edgar C; de Lange M; Vallings R; Tate W
J Transl Med; 2020 Sep; 18(1):365. PubMed ID: 32972442
[TBL] [Abstract][Full Text] [Related]
24. Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Shukla SK; Cook D; Meyer J; Vernon SD; Le T; Clevidence D; Robertson CE; Schrodi SJ; Yale S; Frank DN
PLoS One; 2015; 10(12):e0145453. PubMed ID: 26683192
[TBL] [Abstract][Full Text] [Related]
25. Replacing Myalgic Encephalomyelitis and Chronic Fatigue Syndrome with Systemic Exercise Intolerance Disease Is Not the Way forward.
Twisk FN
Diagnostics (Basel); 2016 Feb; 6(1):. PubMed ID: 26861399
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
de Vega WC; Herrera S; Vernon SD; McGowan PO
BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836
[TBL] [Abstract][Full Text] [Related]
27. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back!
Ariza ME
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33572802
[TBL] [Abstract][Full Text] [Related]
28. A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
Corbitt M; Campagnolo N; Staines D; Marshall-Gradisnik S
Probiotics Antimicrob Proteins; 2018 Sep; 10(3):466-477. PubMed ID: 29464501
[TBL] [Abstract][Full Text] [Related]
29. Suggested pathology of systemic exertion intolerance disease: Impairment of the E
Bohne VJB; Bohne Ø
Med Hypotheses; 2019 Sep; 130():109260. PubMed ID: 31383326
[TBL] [Abstract][Full Text] [Related]
30. Children's experiences of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review and meta-ethnography of qualitative studies.
Parslow RM; Harris S; Broughton J; Alattas A; Crawley E; Haywood K; Shaw A
BMJ Open; 2017 Jan; 7(1):e012633. PubMed ID: 28087544
[TBL] [Abstract][Full Text] [Related]
31. Neuroimaging characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review.
Shan ZY; Barnden LR; Kwiatek RA; Bhuta S; Hermens DF; Lagopoulos J
J Transl Med; 2020 Sep; 18(1):335. PubMed ID: 32873297
[TBL] [Abstract][Full Text] [Related]
32. Unintended Consequences of not Specifying Exclusionary Illnesses for Systemic Exertion Intolerance Disease.
Jason LA; Sunnquist M; Kot B; Brown A
Diagnostics (Basel); 2015 Jun; 5(2):272-86. PubMed ID: 26854153
[TBL] [Abstract][Full Text] [Related]
33. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology.
Wong TL; Weitzer DJ
Medicina (Kaunas); 2021 Apr; 57(5):. PubMed ID: 33925784
[No Abstract] [Full Text] [Related]
34. Evidence for Peroxisomal Dysfunction and Dysregulation of the CDP-Choline Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Che X; Brydges CR; Yu Y; Price A; Joshi S; Roy A; Lee B; Barupal DK; Cheng A; Palmer DM; Levine S; Peterson DL; Vernon SD; Bateman L; Hornig M; Montoya JG; Komaroff AL; Fiehn O; Lipkin WI
medRxiv; 2022 Jan; ():. PubMed ID: 35043127
[TBL] [Abstract][Full Text] [Related]
35. Treatment for paediatric chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) and comorbid depression: a systematic review.
Loades ME; Sheils EA; Crawley E
BMJ Open; 2016 Oct; 6(10):e012271. PubMed ID: 27729349
[TBL] [Abstract][Full Text] [Related]
36. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).
König RS; Albrich WC; Kahlert CR; Bahr LS; Löber U; Vernazza P; Scheibenbogen C; Forslund SK
Front Immunol; 2021; 12():628741. PubMed ID: 35046929
[TBL] [Abstract][Full Text] [Related]
37. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS).
Haffke M; Freitag H; Rudolf G; Seifert M; Doehner W; Scherbakov N; Hanitsch L; Wittke K; Bauer S; Konietschke F; Paul F; Bellmann-Strobl J; Kedor C; Scheibenbogen C; Sotzny F
J Transl Med; 2022 Mar; 20(1):138. PubMed ID: 35317812
[TBL] [Abstract][Full Text] [Related]
38. A Systematic Review of Drug Therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
Collatz A; Johnston SC; Staines DR; Marshall-Gradisnik SM
Clin Ther; 2016 Jun; 38(6):1263-1271.e9. PubMed ID: 27229907
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic Methods for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop.
Haney E; Smith ME; McDonagh M; Pappas M; Daeges M; Wasson N; Nelson HD
Ann Intern Med; 2015 Jun; 162(12):834-40. PubMed ID: 26075754
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
